JP2025114620A5 - - Google Patents
Info
- Publication number
- JP2025114620A5 JP2025114620A5 JP2025072311A JP2025072311A JP2025114620A5 JP 2025114620 A5 JP2025114620 A5 JP 2025114620A5 JP 2025072311 A JP2025072311 A JP 2025072311A JP 2025072311 A JP2025072311 A JP 2025072311A JP 2025114620 A5 JP2025114620 A5 JP 2025114620A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- sequence
- antigen
- binding fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910836601.9 | 2019-09-03 | ||
| CN201910835819.2 | 2019-09-03 | ||
| CN201910835819 | 2019-09-03 | ||
| CN201910836601 | 2019-09-03 | ||
| PCT/CN2020/113287 WO2021043220A1 (zh) | 2019-09-03 | 2020-09-03 | 抗cd47的单克隆抗体及其用途 |
| JP2022513964A JP7808546B2 (ja) | 2019-09-03 | 2020-09-03 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513964A Division JP7808546B2 (ja) | 2019-09-03 | 2020-09-03 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025114620A JP2025114620A (ja) | 2025-08-05 |
| JP2025114620A5 true JP2025114620A5 (enExample) | 2026-05-19 |
Family
ID=74736180
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513964A Active JP7808546B2 (ja) | 2019-09-03 | 2020-09-03 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
| JP2025072311A Pending JP2025114620A (ja) | 2019-09-03 | 2025-04-24 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513964A Active JP7808546B2 (ja) | 2019-09-03 | 2020-09-03 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220324971A1 (enExample) |
| EP (1) | EP4026847A4 (enExample) |
| JP (2) | JP7808546B2 (enExample) |
| KR (1) | KR20220053665A (enExample) |
| CN (1) | CN112442123B (enExample) |
| AU (1) | AU2020342192A1 (enExample) |
| BR (1) | BR112022003868A2 (enExample) |
| CA (1) | CA3148956A1 (enExample) |
| IL (1) | IL291049A (enExample) |
| MX (1) | MX2022002505A (enExample) |
| PH (1) | PH12022550489A1 (enExample) |
| WO (1) | WO2021043220A1 (enExample) |
| ZA (1) | ZA202203622B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024515396A (ja) * | 2021-04-14 | 2024-04-10 | 中山康方生物医▲藥▼有限公司 | 抗ｃｄ４７モノクローナル抗体及びその使用 |
| WO2023191117A1 (ko) * | 2022-03-28 | 2023-10-05 | (주)이노베이션바이오 | 친화도가 성숙된 cd47에 특이적인 인간화 항체 |
| CN117229398A (zh) * | 2022-06-15 | 2023-12-15 | 中山康方生物医药有限公司 | 抗cldn18.2抗体、其药物组合物及用途 |
| CN120714022A (zh) * | 2024-03-27 | 2025-09-30 | 康方汇科(上海)生物有限公司 | 药物组合及用途 |
| WO2026051964A1 (en) * | 2024-09-04 | 2026-03-12 | Akeso Biopharma Co., Ltd. | Antibody that binds vegfa and pd-1 and uses thereof to treat cancers |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| WO1988001649A1 (en) | 1986-09-02 | 1988-03-10 | Genex Corporation | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| EP4349868A3 (en) | 2010-05-14 | 2024-08-28 | The Board of Trustees of the Leland Stanford Junior University | Humanized and chimeric monoclonal antibodies to cd47 |
| RU2015122228A (ru) * | 2012-12-12 | 2017-01-19 | Васкулокс Инк. | Терапевтические антитела к CD47 |
| WO2017049251A2 (en) * | 2015-09-18 | 2017-03-23 | Tioma Therapeutics, Inc. | Therapeutic cd47 antibodies |
| HK1257309A1 (zh) * | 2015-09-21 | 2019-10-18 | Erasmus University Medical Center | 抗-cd47抗体及使用方法 |
| ES2796378T3 (es) * | 2016-01-11 | 2020-11-26 | Forty Seven Inc | Anticuerpos monoclonales anti-cd47 humanizados, de ratón o químicos |
| KR102607101B1 (ko) | 2017-01-26 | 2023-11-29 | 제트엘아이피 홀딩 리미티드 | Cd47 항원 결합 유닛 및 그것의 사용 |
| CN109422811A (zh) | 2017-08-29 | 2019-03-05 | 信达生物制药(苏州)有限公司 | 抗cd47抗体及其用途 |
| US20220298254A1 (en) | 2017-11-01 | 2022-09-22 | Hummingbird Bioscience Holdings Pte. Ltd. | Cd47 antigen-binding molecules |
| WO2019129054A1 (zh) | 2017-12-27 | 2019-07-04 | 信达生物制药(苏州)有限公司 | 三链抗体、其制备方法及其用途 |
| AU2019212674A1 (en) | 2018-01-24 | 2020-09-03 | Nanjing Legend Biotech Co., Ltd. | Anti-CD47 antibodies that do not cause significant red blood cell agglutination |
| CN109265547B (zh) | 2018-07-23 | 2022-07-26 | 中国科学院微生物研究所 | 一种抗cd47抗体及其应用 |
| CN109438576B (zh) * | 2018-11-14 | 2021-08-20 | 上海交通大学 | 一种抗人cd47单克隆抗体的制备及其应用 |
| CN118459587A (zh) * | 2019-02-01 | 2024-08-09 | 启晨佰泰(北京)医药科技有限公司 | 抗cd47抗体及其应用 |
-
2020
- 2020-09-03 US US17/640,005 patent/US20220324971A1/en active Pending
- 2020-09-03 WO PCT/CN2020/113287 patent/WO2021043220A1/zh not_active Ceased
- 2020-09-03 MX MX2022002505A patent/MX2022002505A/es unknown
- 2020-09-03 AU AU2020342192A patent/AU2020342192A1/en active Pending
- 2020-09-03 KR KR1020227010974A patent/KR20220053665A/ko active Pending
- 2020-09-03 CA CA3148956A patent/CA3148956A1/en active Pending
- 2020-09-03 PH PH1/2022/550489A patent/PH12022550489A1/en unknown
- 2020-09-03 BR BR112022003868A patent/BR112022003868A2/pt unknown
- 2020-09-03 JP JP2022513964A patent/JP7808546B2/ja active Active
- 2020-09-03 EP EP20861103.8A patent/EP4026847A4/en active Pending
- 2020-09-03 CN CN202010919545.8A patent/CN112442123B/zh active Active
-
2022
- 2022-03-02 IL IL291049A patent/IL291049A/en unknown
- 2022-03-29 ZA ZA2022/03622A patent/ZA202203622B/en unknown
-
2025
- 2025-04-24 JP JP2025072311A patent/JP2025114620A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111944050B (zh) | 一种抗b7-h3抗体及其应用 | |
| CN115551888B (zh) | 抗cd73抗体及其用途 | |
| CA2987118C (en) | A pdl-1 antibody, pharmaceutical composition thereof and use thereof | |
| CN101970497B (zh) | 抗‑EpCAM抗体及其用途 | |
| JP2021526022A5 (enExample) | ||
| JP2023539501A5 (enExample) | ||
| JP2023546743A5 (enExample) | ||
| KR20230154317A (ko) | 항-cldn6 항체 및 이의 용도 | |
| JP2024540148A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| RU2020130795A (ru) | Нейтрализующие антитела к env вич-1 и их применение | |
| JP2024506315A5 (enExample) | ||
| JP2023522730A5 (enExample) | ||
| JP2022539589A5 (enExample) | ||
| CN117279950B (zh) | 一种靶向il-18bp的抗体及其应用 | |
| RU2019135404A (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| JP2024532836A5 (enExample) | ||
| JP2022544050A5 (enExample) | ||
| CN117177999B (zh) | 一种靶向IL-18Rβ的抗体及其应用 | |
| CN120554514B (zh) | 一种靶向人的叶酸受体α的单克隆抗体 | |
| JP2025516590A5 (enExample) | ||
| JP2024516621A5 (enExample) | ||
| JP2024519078A5 (enExample) | ||
| AU2021474386A1 (en) | Bispecific antibody and use thereof | |
| CN119775424A (zh) | 抗bcma抗体及其应用 |